These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 3265693

  • 21. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
    Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blättler WA.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6236-42. PubMed ID: 1718599
    [Abstract] [Full Text] [Related]

  • 22. Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin.
    Frankel AE, Laver JH, Willingham MC, Burns LJ, Kersey JH, Vallera DA.
    Leuk Lymphoma; 1997 Jul 01; 26(3-4):287-98. PubMed ID: 9322891
    [Abstract] [Full Text] [Related]

  • 23. Ex vivo perfusion of intestinal allografts with anti-T cell monoclonal antibody/ricin A chain conjugates for the suppression of graft-versus-host disease.
    Smith GJ, Ingham-Clark C, Crane P, Lear P, Wood RF, Fabre JW.
    Transplantation; 1992 Apr 01; 53(4):717-22. PubMed ID: 1566334
    [Abstract] [Full Text] [Related]

  • 24. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
    Weiner LM, O'Dwyer J, Kitson J, Comis RL, Frankel AE, Bauer RJ, Konrad MS, Groves ES.
    Cancer Res; 1989 Jul 15; 49(14):4062-7. PubMed ID: 2786751
    [Abstract] [Full Text] [Related]

  • 25. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J, Johnson VG, Youle RJ.
    J Neurosurg; 1987 Jun 15; 66(6):850-61. PubMed ID: 3033171
    [Abstract] [Full Text] [Related]

  • 26. Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxins.
    Engert A, Gottstein C, Winkler U, Amlot P, Pileri S, Diehl V, Thorpe P.
    Leuk Lymphoma; 1994 May 15; 13(5-6):441-8. PubMed ID: 8069189
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G.
    Cancer Res; 1988 May 01; 48(9):2610-7. PubMed ID: 2451562
    [Abstract] [Full Text] [Related]

  • 28. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
    Fulton RJ, Uhr JW, Vitetta ES.
    Cancer Res; 1988 May 01; 48(9):2626-31. PubMed ID: 3258547
    [Abstract] [Full Text] [Related]

  • 29. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.
    Trown PW, Reardan DT, Carroll SF, Stoudemire JB, Kawahata RT.
    Cancer Res; 1991 Aug 15; 51(16):4219-25. PubMed ID: 1868442
    [Abstract] [Full Text] [Related]

  • 30. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ.
    Cancer Res; 1989 Nov 01; 49(21):6153-60. PubMed ID: 2790828
    [Abstract] [Full Text] [Related]

  • 31. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
    Shah SA, Halloran PM, Ferris CA, Levine BA, Bourret LA, Goldmacher VS, Blättler WA.
    Cancer Res; 1993 Mar 15; 53(6):1360-7. PubMed ID: 7680284
    [Abstract] [Full Text] [Related]

  • 32. Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.
    Bourrie BJ, Casellas P, Blythman HE, Jansen FK.
    Eur J Biochem; 1986 Feb 17; 155(1):1-10. PubMed ID: 3948873
    [Abstract] [Full Text] [Related]

  • 33. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U, Collinson AR, Fisch I, Jones RM, Waibel R, Lehman HP, Stahel RA.
    Int J Cancer; 1993 Jul 30; 54(6):1028-35. PubMed ID: 8392978
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.
    Tonevitsky AG, Agapov II, Mechetner EB, Ershova GV, Toptygin AYu, Sarma T, Shamshiev AT, Pfueller U.
    Biochem Mol Biol Int; 1993 Dec 30; 31(6):1059-69. PubMed ID: 8193589
    [Abstract] [Full Text] [Related]

  • 35. Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
    Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA.
    Blood; 1992 Feb 01; 79(3):576-85. PubMed ID: 1370636
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.
    Fishwild DM, Aberle S, Bernhard SL, Kung AH.
    Cancer Res; 1992 Jun 01; 52(11):3056-62. PubMed ID: 1375534
    [Abstract] [Full Text] [Related]

  • 37. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
    Byers VS, Baldwin RW.
    Semin Cell Biol; 1991 Feb 01; 2(1):59-70. PubMed ID: 1954344
    [Abstract] [Full Text] [Related]

  • 38. The activity of two immunotoxins composed of monoclonal antibody MoAb-16 and A-chain of ricin (MoAb-16-RTA) or A-chain of mistletoe lectin I (MoAb-16-MLIA).
    Paprocka M, Wiedłocha A, Walzel H, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1992 Feb 01; 40(3-4):223-7. PubMed ID: 1300987
    [Abstract] [Full Text] [Related]

  • 39. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H, King L, Lasky LC, Vallera DA.
    Cancer Res; 1990 Jun 01; 50(11):3249-56. PubMed ID: 1692258
    [Abstract] [Full Text] [Related]

  • 40. Endocytosis and intracellular routing of an antibody-ricin A chain conjugate.
    Calafat J, Molthoff C, Janssen H, Hilkens J.
    Cancer Res; 1988 Jul 01; 48(13):3822-7. PubMed ID: 3132322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.